+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Apheresis Devices Market by Product and Geography - Forecast and Analysis 2020-2024 - Product Image

Apheresis Devices Market by Product and Geography - Forecast and Analysis 2020-2024

  • ID: 4871425
  • Report
  • November 2019
  • Region: Global
  • 151 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Cerus Corp.
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • MORE
Global Apheresis Devices Market: About this market
The apheresis devices market analysis considers sales from both systems and consumable products. Our study also finds the sales of apheresis devices in Asia, Europe, North America, and ROW. In 2019, the apheresis system segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of surgical procedures and increasing technological advances will play a significant role in the apheresis system segment to maintain its market position. Also, our global apheresis devices market report looks at factors such as increasing prevalence of chronic diseases, rising number of new product launches, and growing number of surgical procedures associated with trauma and injury cases. However, high costs associated with apheresis devices and procedures, lack of awareness about apheresis process, and shortage of donors required for apheresis process may hamper the growth of the apheresis devices industry over the forecast period.

Global Apheresis Devices Market: Overview

Growing number of surgical procedures associated with trauma and injury cases
The growing prevalence of various diseases have augmented the number of surgeries around the world. However, surgeries may result in severe blood loss. This increases the demand for blood transfusion using apheresis devices. Moreover, with the increase in the instances of injuries, the demand for apheresis devices in emergency departments of hospitals and clinics is increasing, which will lead to the expansion of the global apheresis devices market at a CAGR of over 6% during the forecast period.

Technological advances
The growing technological innovations have enabled a paradigm shift in cost as well as the manageability of medical equipment. Technologically advanced and innovative devices are mainly used by healthcare professionals for the apheresis process to obtain high-quality blood components. Vendors are focusing on the development of next-generation advanced apheresis devices with screen navigation, automated interface system, and graphical user interface display. The next-generation advanced apheresis devices help healthcare providers to offer effective and accurate patient care with high quality and integrity. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global apheresis devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading apheresis devices manufacturers, that include Asahi Kasei Corp., B. Braun Melsungen AG, Cerus Corp., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corp., HemaCare Corp., Kaneka Corp., Kawasumi Laboratories Inc., Nikkiso Co. Ltd., and Terumo Corp.

Also, the apheresis devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Cerus Corp.
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Systems - Market size and forecast 2019-2024
  • Consumables - Market size and forecast 2019-2024
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Technological advances
  • Business strategies
  • Growth in new indications for plasma products
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Cerus Corp.
  • Fresenius Medical Care AG & Co. KGaA
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • Kawasumi Laboratories Inc.
  • Nikkiso Co. Ltd.
  • Terumo Corp.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global healthcare equipment market
Exhibit 03: Segments of global healthcare equipment market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Systems - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Systems - Year-over-year growth 2020-2024 (%)
Exhibit 22: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Business strategies and their market impact analysis
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Asahi Kasei Corp. - Vendor overview
Exhibit 47: Asahi Kasei Corp. - Product segments
Exhibit 48: Asahi Kasei Corp. - Organizational developments
Exhibit 49: Asahi Kasei Corp. - Geographic focus
Exhibit 50: Asahi Kasei Corp. - Segment focus
Exhibit 51: Asahi Kasei Corp. - Key offerings
Exhibit 52: Asahi Kasei Corp. - Key customers
Exhibit 53: B. Braun Melsungen AG - Vendor overview
Exhibit 54: B. Braun Melsungen AG - Business segments
Exhibit 55: B. Braun Melsungen AG - Organizational developments
Exhibit 56: B. Braun Melsungen AG - Geographic focus
Exhibit 57: B. Braun Melsungen AG - Segment focus
Exhibit 58: B. Braun Melsungen AG - Key offerings
Exhibit 59: B. Braun Melsungen AG - Key customers
Exhibit 60: Cerus Corp. - Vendor overview
Exhibit 61: Cerus Corp. - Business segments
Exhibit 62: Cerus Corp. - Organizational developments
Exhibit 63: Cerus Corp. - Geographic focus
Exhibit 64: Cerus Corp. - Key offerings
Exhibit 65: Cerus Corp. - Key customers
Exhibit 66: Fresenius Medical Care AG & Co. KGaA - Vendor overview
Exhibit 67: Fresenius Medical Care AG & Co. KGaA - Business segments
Exhibit 68: Fresenius Medical Care AG & Co. KGaA - Organizational developments
Exhibit 69: Fresenius Medical Care AG & Co. KGaA - Geographic focus
Exhibit 70: Fresenius Medical Care AG & Co. KGaA - Segment focus
Exhibit 71: Fresenius Medical Care AG & Co. KGaA - Key offerings
Exhibit 72: Fresenius Medical Care AG & Co. KGaA - Key customers
Exhibit 73: Haemonetics Corp. - Vendor overview
Exhibit 74: Haemonetics Corp. - Business segments
Exhibit 75: Haemonetics Corp. - Organizational developments
Exhibit 76: Haemonetics Corp. - Geographic focus
Exhibit 77: Haemonetics Corp. - Segment focus
Exhibit 78: Haemonetics Corp. - Key offerings
Exhibit 79: Haemonetics Corp. - Key customers
Exhibit 80: HemaCare Corp. - Vendor overview
Exhibit 81: HemaCare Corp. - Product segments
Exhibit 82: HemaCare Corp. - Organizational developments
Exhibit 83: HemaCare Corp. - Key offerings
Exhibit 84: HemaCare Corp. - Key customers
Exhibit 85: Kaneka Corp. - Vendor overview
Exhibit 86: Kaneka Corp. - Business segments
Exhibit 87: Kaneka Corp. - Organizational developments
Exhibit 88: Kaneka Corp. - Geographic focus
Exhibit 89: Kaneka Corp. - Segment focus
Exhibit 90: Kaneka Corp. - Key offerings
Exhibit 91: Kaneka Corp. - Key customers
Exhibit 92: Kawasumi Laboratories Inc. - Vendor overview
Exhibit 93: Kawasumi Laboratories Inc. - Business segments
Exhibit 94: Kawasumi Laboratories Inc. - Key offerings
Exhibit 95: Kawasumi Laboratories Inc. - Key customers
Exhibit 96: Nikkiso Co. Ltd. - Vendor overview
Exhibit 97: Nikkiso Co. Ltd. - Business segments
Exhibit 98: Nikkiso Co. Ltd. - Geographic focus
Exhibit 99: Nikkiso Co. Ltd. - Segment focus
Exhibit 100: Nikkiso Co. Ltd. - Key offerings
Exhibit 101: Nikkiso Co. Ltd. - Key customers
Exhibit 102: Terumo Corp. - Vendor overview
Exhibit 103: Terumo Corp. - Business segments
Exhibit 104: Terumo Corp. - Organizational developments
Exhibit 105: Terumo Corp. - Geographic focus
Exhibit 106: Terumo Corp. - Segment focus
Exhibit 107: Terumo Corp. - Key offerings
Exhibit 108: Terumo Corp. - Key customers
Exhibit 109: Validation techniques employed for market sizing
Exhibit 110: Definition of market positioning of vendors

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Cerus Corp.
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • MORE
The following companies as the key players in the global apheresis devices market: Asahi Kasei Corp., B. Braun Melsungen AG, Cerus Corp., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corp., HemaCare Corp., Kaneka Corp., Kawasumi Laboratories Inc., Nikkiso Co. Ltd., and Terumo Corp.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”

According to the report, one of the major drivers for this market is the growing number of surgical procedures associated with trauma and injury cases.

Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with apheresis devices and procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Cerus Corp.
  • Fresenius Medical Care AG & Co. KGaA
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • Kawasumi Laboratories Inc.
  • Nikkiso Co. Ltd.
  • Terumo Corp.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll